Anika Therapeutics, Inc. (ANIK) Shareholders’ equity 2016–2025
Anika Therapeutics, Inc. (ANIK) shareholders’ equity at each fiscal year-end, per SEC filings.
$143.5MFY2025 · since FY2016: $222.8M → $143.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $143.5M | -6.8% |
| FY2024 | $154.0M | -27.5% |
| FY2023 | $212.3M | -25.7% |
| FY2022 | $285.6M | -0.5% |
| FY2021 | $287.1M | +5.4% |
| FY2020 | $272.4M | -5.5% |
| FY2019 | $288.4M | +9.4% |
| FY2018 | $263.6M | +0.0% |
| FY2017 | $263.5M | +18.3% |
| FY2016 | $222.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice